|
LRP8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33039999963935E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59069999949857E-07 |
| Normal-vs-Stage2 |
1.153450E-01 |
| Normal-vs-Stage3 |
3.72900000000786E-06 |
| Normal-vs-Stage4 |
2.86948242944618E-12 |
| Stage1-vs-Stage2 |
8.165800E-02 |
| Stage1-vs-Stage3 |
4.379200E-01 |
| Stage1-vs-Stage4 |
1.87050000000077E-06 |
| Stage2-vs-Stage3 |
4.252100E-02 |
| Stage2-vs-Stage4 |
2.987300E-04 |
| Stage3-vs-Stage4 |
2.702200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27449999999907E-05 |
| Normal-vs-AfricanAmerican |
4.05875333342465E-12 |
| Normal-vs-Asian |
2.79132272851257E-12 |
| Caucasian-vs-AfricanAmerican |
9.13840000005273E-07 |
| Caucasian-vs-Asian |
9.6355999956721E-08 |
| AfricanAmerican-vs-Asian |
8.676600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7495000437815E-09 |
| Normal-vs-Female |
3.60870000004621E-06 |
| Male-vs-Female |
2.369200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07650000422421E-08 |
| Normal-vs-Age(41-60Yrs) |
2.32870000005381E-06 |
| Normal-vs-Age(61-80Yrs) |
2.15290000005197E-06 |
| Normal-vs-Age(81-100Yrs) |
1.248410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.821200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.135200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.871200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.429600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.219400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.929200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.21565038222616E-13 |
| Classical-VS-Follicular |
3.915000E-01 |
| Classical-VS-Other |
3.288200E-02 |
| Classical-VS-Normal |
2.46179999996432E-06 |
| Tall-VS-Follicular |
3.04019999952665E-07 |
| Tall-VS-Other |
3.345000E-01 |
| Tall-VS-Normal |
4.10782519111308E-14 |
| Follicular-VS-Other |
1.498010E-02 |
| Follicular-VS-Normal |
1.161610E-03 |
| Other-VS-Normal |
4.77290000000519E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.186030E-04 |
| Normal-vs-N1 |
1.73512999999126E-05 |
| N0-vs-N1 |
8.499800E-02 |
|
|
